Roy Poses: “Flawed research that supports an expensive, high-technology intervention for which millions of people would be eligible appears in a major journal. The intervention is hyped in news articles, and by a grass roots patient advocacy group. Politicians soon jump on the bandwagon. Citing the potential for saving lives, enthusiasts ignore the flaws in the data that started it all. Only much later do we find out that the researchers who wrote the flawed study may stand to make money if the high-technology intervention is widely adopted.”
Related posts:
- Lung cancer screening
- CT scans and lung cancer screening
- Lung cancer CT screening produces false positives and isn’t ready for prime time
- CT scans and lung cancer screening redux
- Colon cancer screening guidelines
- Why health reformers should be worried about the breast cancer screening backlash
- Should tobacco companies pay for smokers’ CT scans to screen for lung cancer?
KevinMD.com on Facebook
Comments on this entry are closed.